Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Allogene Therapeutics stock in Canada
Own Allogene Therapeutics shares in just a few minutes.
Allogene Therapeutics is a biotechnology business based in the US. Allogene Therapeutics stocks (ALLO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $24.18 – a decrease of 4.46% over the previous week. Allogene Therapeutics employs 301 staff and has a trailing 12-month revenue of around $38.4 million.
How to buy shares in Allogene Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ALLO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy Allogene Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in Allogene Therapeutics?
- Has coronavirus impacted Allogene Therapeutics shares?
- Allogene Therapeutics shares summary
- Compare share dealing platforms
- Is Allogene Therapeutics stock a buy or sell?
- Allogene Therapeutics performance over time
- Allogene Therapeutics's financials
- How volatile are Allogene Therapeutics shares?
- Does Allogene Therapeutics pay a dividend?
- Other common questions
How has Coronavirus impacted Allogene Therapeutics's stock price?
Since the stock market crash in March caused by coronavirus, Allogene Therapeutics's stock price has had significant negative movement.
Its last market close was $11.78, which is 54.71% down on its pre-crash value of $26.01 and 47.96% down on the lowest point reached during the March crash when the stocks fell as low as $17.43.
If you had bought $1,000 worth of Allogene Therapeutics stocks at the start of February 2020, those stocks would have been worth $869.71 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $538.94.
Allogene Therapeutics stock price (NASDAQ:ALLO)Use our graph to track the performance of ALLO stocks over time.
Allogene Therapeutics shares at a glance
|Latest market close||$11.78|
|52-week range||$11.54 - $39.12|
|50-day moving average||$16.64|
|200-day moving average||$22.72|
|Wall St. target price||$32.38|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.88|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Allogene Therapeutics price performance over time
|1 week (2022-01-11)||-8.68%|
|1 month (2021-12-17)||-25.49%|
|3 months (2021-10-18)||-25.11%|
|6 months (2021-07-19)||-47.13%|
|1 year (2021-01-19)||-62.72%|
|2 years (2020-01-17)||-53.48%|
|3 years (2019-01-18)||28.58|
|5 years (2017-01-15)||N/A|
Allogene Therapeutics financials
|Revenue TTM||$38.4 million|
|Gross profit TTM||$0|
|Return on assets TTM||-13.65%|
|Return on equity TTM||-24.01%|
|Market capitalisation||$1.9 billion|
TTM: trailing 12 months
Allogene Therapeutics share dividends
We're not expecting Allogene Therapeutics to pay a dividend over the next 12 months.
Allogene Therapeutics share price volatility
Over the last 12 months, Allogene Therapeutics's shares have ranged in value from as little as $11.54 up to $39.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Allogene Therapeutics's is 0.7013. This would suggest that Allogene Therapeutics's shares are less volatile than average (for this exchange).
Allogene Therapeutics overview
Allogene Therapeutics, Inc. , a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell ALL. The company also develops ALLO-501, an anti-CD19 allogeneic CAR T cell product candidate that is in Phase I clinical trial for the treatment of R/R non-Hodgkin lymphoma; and ALLO-501A, which is in Phase I/II clinical trial for the treatment R/R large B-cell lymphoma or transformed follicular lymphoma. In addition, it is developing ALLO-715, an allogeneic CAR T cell product candidate that is in a Phase I clinical trial for treating R/R multiple myeloma; ALLO-819, an allogeneic CAR T cell product candidates for the treatment of acute myeloid leukemia; ALLO-605, an allogeneic CAR T cell product candidate for the treatment of multiple myeloma; ALLO-647, an anti-CD52 monoclonal antibody; CD70 to treat renal cell cancer; and DLL3 for the treatment of small cell lung cancer and other aggressive neuroendocrine tumors. The company has license and collaboration agreements with Pfizer Inc. ; Servier; Cellectis S.
Stocks similar to Allogene Therapeutics
Frequently asked questions
Allogene Therapeutics in the news
Top Stocks To Invest In Right Now? 5 Health Care Stocks To Watch
Insider Weekends: Daniel Springer Buys More DocuSign
Allogene Therapeutics Inc Shares Close the Day 11.0% Higher - Daily Wrap
More guides on Finder
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.
GreenTrust (GNT) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy GreenTrust, lists some exchanges where you can get it and provides daily price data on GNT.
FUNToken (FUN) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy FUNToken, lists some exchanges where you can get it and provides daily price data on FUN.
Ask an Expert
You must be logged in to post a comment.